Donald R. MarvinPresident and CEOIdentiGEN North America, Inc.Donald Marvin
has been a biotechnology entrepreneur and leader in the commercialization of new life sciences diagnostic and research technologies and products for more than 25 years.Before joining IdentiGEN, he was the president and CEO of Cairn Associates, Inc., a life sciences strategy consulting and investment firm.He was a co-founder of Nasdaq-traded Orchid BioSciences, a pioneer in human DNA identity testing, where he served as its chief operating officer, chief financial officer and senior vice president of corporate development.Previously, Marvin was president and CEO of Diatron Corporation, a biomedical company developing fluorescence-based instrument systems for the clinical diagnostics industry.His prior experience includes strategic planning, business development, technical administration and operations at PepsiCo, Abbott Laboratories and Bayer AG, as well as domestic and international marketing and sales for the clinical diagnostics subsidiary of Boehringer Ingelheim.Marvin
, named New Jersey's CFO of the Year 2001, is an experienced fund-raiser, having completed private and public financings that have raised over $250 million for his
companies.He currently serves on the Board of Directors of Tepnel Life Sciences PLC and Melior Discovery, Inc.He received his B.S. degree from Ohio State University and his M.B.A. from Iona College.Marvin
currently lives in the greater Princeton, N.J., area with his
wife, Kristine, and is in the process of relocating to the High Plains region.He participates in several angel investment groups and is the co-founder and former co-host of VentureTalkTM Radio, a show designed to bring together entrepreneurs, sources of capital and service providers.